Clinical Trial Update: DC Vaccine in Pancreatic Cancer [Phase 1]

View source ↗

Summary

This Phase 1 trial update shows a completed study of a dendritic cell vaccine in pancreatic ductal adenocarcinoma, sponsored by the University of Pennsylvania.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• DC Vaccine

Snippet

Sponsor: University of Pennsylvania | Conditions: Pancreatic Ductal Adenocarcinoma | Phase 1 | Status: COMPLETED